We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Finished at US$19.50 (day's high) yesterday on volume of 10,500 shares traded.
At the close the "Ask" varied in a range between US$20.08 and US$28.01, so plenty of upside can be anticipated to break through the US$20 resistance point when trading resumes on Monday.
FFWD likely to follow suit on AIM.
Jim Mellon is sitting pretty at the start of the year with all his investments in demand and active ... let's hope he wakes SALV up from its slumber.
AS we have had no communication from SALV, I did some digging and found that the company is languishing in the Isle of Man and has been administered by;-
Sophia Birchall - LJ Management (IOM) Limited
Commerce House
1 Bowring Road
Ramsay
Isle of Man, IM8 2LQ
The website has been removed and it was on one of the early links. Along the lines of...we will seek an asset, if this doesn’t happen the shares will be passed on to Salv holders.
Value of those shares is now $8.5m!
Placebo,
Maybe worth you monitoring what is going on at BOU.L (following delisting and awaiting news of RTO).
Jim Mellon is busy with his new baby Agronomics (ANIC.L) involved in the development of synthetic meat products and Juvenescence, the anti-ageing technology where there has been a delay to its anticipated IPO caused by the current world pandemic and its impact on the financial situation.
He has a lot of balls in the air, so collaboration with others is key to making progress, SALV could be the vehicle that achieves this.
Portage hit $15.0 on CSE yesterday, only small trades though on turnover of 2,350 shares.
Remember this was $8.85 between 4th & 9th November and has steadily risen since boosted by the November 30th financial statement and report.
Plenty of upside on what is being envisaged for 2021.
Thank you Kentan. I’ll keep an eye out for any further updates.
The last report said they were in ongoing negotiations (RTO?) to become involved with another company to return to a full listing. This has met delays due to the Covid situation and various regulatory conditions to be met.
Funnily enough, the same has been said by another suspended company, Bould Opportunities plc (BOU) who it has been confirmed are in advanced negotiations with a "cancer detection biotechnology company" ... could it be SALV? ... both have said the same and were delisted around the same time. Would be a coincidence.
Does anyone have any news regarding this company?
https://webfiles.thecse.com/sedar_filings/00008656/2011301547192136.pdf
Very detailed and informative.
MANAGEMENT’S DISCUSSION AND ANALYSIS
Prepared as of November 30, 2020
https://webfiles.thecse.com/sedar_filings/00008656/2011301546339474.pdf
Portage Biotech SP on CSE has risen to $13.25 since these reports ... and rising.
1971Bod - where did you get that information from?
don't get me wrong, i'd be very happy if that's the case,
Just wondering if there's any confirmation
thanks
James
Of they don’t relist we get a share divi, more portage shares!!!
i meant salv
are we ever going to get anything from sale again or will it just show up as zero in my account forever haha ??
I hope you’re all keeping up with the news!! Head over to twat her #ptgef
Portage Announces Filing of Q1 Interim Financial Statements; Correction to SalvaRX Loan Note Settlement Announcement 16/10/2020
https://webfiles.thecse.com/66188.pdf?VCbcbZf3S_3A5a_gZzYl3yd1nd78ND42
Portage Issues Common Shares and Warrants in Settlement of SalvaRx Loan Note Obligations 13/10/2020
https://webfiles.thecse.com/65766.pdf?kRWZg2I7I25iig6.kO77R0zkmnzj3cqE
i just seen in my ii isa account my portage share are now showing value.
So because this is delisted, can it not list again as it’s over it’s 6 month period. Anyone have any info. Cheers.
Hi All,
First time posting here.
I am with ii and am awaiting my Portage shares also. I have had email correspondance with them on the potential to trade the shares via the platform. The most recent answer from them is that i can trade them on the CSE via ii, albeit it will have to be a telephone trade. The trade will also be subject to currency conversion as my ii account is an ISA.
However, I'm not convinced this response from ii is accurate as i had previously been told that i couldn't trade the shares on the CSE. And that seems to be the information others here have received.
Who knows!
https://webfiles.thecse.com/PR62620.pdf?BJd2bGH6VndhFMk8l5Svoe.938xNpofj
Results of meeting on 26th June 2020 ... annual meeting for re-election of directors and corporate finance placement.
In the fast-moving Covid-19 biotech world, there are 2 Australian companies worth Jim Mellon & Co. getting involved with (as investors or JV's to increase their worldwide expansion). Both are early days and in the right area.
DIMERIX LTD .... ASX:DXB
Have just completed an AUD$5.8m placement by institutions towards their global Phase 3 Covid-19 trials.
https://stockhead.com.au/health/institutions-back-hotshot-dimerix-for-covid-19-study/
CYNATA THERAPEUTICS ... ASX:CYP
Advanced Stem Cell studies for treatment of Covid-19 patients backed by USA University of Wisconsin-Madison technology.
https://stockhead.com.au/health/health-kick-cynatas-stem-cell-therapy-could-be-a-game-changer-for-covid-19-patients/
Portage Biotech & Salvarx would benefit both projects with exposure to UK & USA markets.
I am on Telegram but could not find Quint's Portage 2 group, any idea of the correct username?
When is a Medallion Signature Guarantee required?
Generally, a Medallion Signature Guarantee is required when an owner wants to sell or transfer securities held in physical certificate form, including stocks or bonds. If the securities are held through a broker, the owner will not need to obtain a Medallion Signature Guarantee.
Hi Pesto,
Portage are tradeable from Monday/tuesday 8th/9th; New listing (s) to be announced in due course.
Are you in Quints Portage 2 telegram group ?? There are around 150 Portage holders in there with all the answers !
Jesterman,
Im assuming if i do nothing and sit on the Portage Shares in my II ISA, albeit no value or not tradeable in the hope that when Portage do indeed become tradeable on Senior Listing and ii ISA will then recognise, at that point they become tradeable? I believe the senior listing for Portage is imminent, NASDAQ?